Advancing acid labile or sensitive APIs is often slowed by coating steps that add time and complexity. This webinar offers a concise, science led look at recent data supporting the performance of a coating free, intrinsically enteric hard capsule, evaluated across established methods and studies.
We will focus on how capsule performance has been evaluated across compendial, in vitro, biorelevant, and in vivo methods, and we will outline customization options to support development from lab to proof of concept.
What is covered:
Why watch?
Watch this webinar on-demand to learn how Capsugel® Enprotect® capsules and our Innovaform® Accelerator customization capabilities can accelerate early development, simplify scale up, and enable innovative drug delivery strategies.
Dr Camille Dumont
Manager, Customer Applications – Capsule Application Lab
Camille Dumont is Capsule Application Manager at Lonza Capsugel, working within the Innovaform Accelerator team. In this role, she leads a team dedicated to developing custom formulations and assessing the pharmaceutical performance of capsules, with the goal of addressing complex drug delivery challenges through capsule innovation.
With over 10 years of experience in the pharmaceutical industry, Camille has developed deep expertise in creating advanced solutions to enhance drug bioavailability. Her particular focus lies in lipid-based formulations designed to improve the oral delivery of small molecules and peptides. Camille holds a Master’s degree in Chemistry and Formulation and a PhD in Pharmaceutical Sciences from the University of Lyon.
Dr Dumont has a distinguished publication record, including 13 peer-reviewed journal articles (h-index=8, > 344 citations), and 20 abstracts in international conferences in Drug Delivery Systems.
Latest CHI content